Lecture 2: Clinical pharmacokinetics and pharmacodynamics Flashcards
What is elimination of a drug?
Metabolism and excretion
What is the importance of pharmacokinetics?
- population and patient specific tailoring
- predicting toxicity, review all medications (the addition of one new agent could be significant)
What pharmacokinetic properties need to be considered by the MRHRA (medicines and healthcare products regulatory agency)?
- bioavailability
- half-life
- drug elimination
- inter-subject variability
- drug-drug reactions
What factors influence some pharmacokinetic principles?
- renal function
- stress
- pyrexia
- alcohol/smoking
- age/sex
- exercise/diet/occupational exposure
- infection
- lactation
- liver/CVS/GI function
- pregnancy
- immunisation
- circadian and seasonal variations
What is bioavailability (F)?
Measure of drug absorption where it can be used
- drug administered via IV has 100% bioavailability
- for other routes it is referenced as a fraction of IV
What is bioavailability affected by?
Absorption
- formulation (composition of the drug)
- age (luminal changes)
- food (with or without food)
- vomiting/malabsorption
- previous surgery (bariatric)
First pass metabolism
-metabolism before reaching systemic circulation (gut lumen/gut wall/liver/lungs)
What can plasma concentration-time graphs show us?
Y axis: plasma conc of drug
X axis: time
- can show distinct phases e.g. absorption-rise in plasma conc, distribution- small pronounced drop, elimination- run off phase
- if absorption is slow, the absorption and distribution phases are resolved separately
- initial gradient of line- rate of absorption
What are modified release preparations (e.g. tablet capsule/type)?
Used to prevent rapid large fluctuations in plasma drug concentration due to rapid elimination
- more gradual absorption (plasma conc becomes more dependant on rate of absorption rather than rate of elimination)
- increases adherence
What is distribution of a drug?
We need adequate plasma levels to reach the target organs
What factors affect the distribution of a drug/theraputic agent?
- blood flow/capillary structure
- lipophilicity/hydrophilicity
- protein binding (albumin: acidic drugs, causing sequestering/glycoproteins: basic drugs/globulins/lipoproteins)
How do you interpret a concentration time graph for distribution?
In plasma:
- first drop is due to movement of drug in plasma to the well perfused tissue
- second drop due to perfusion of poorly perfused tissues
Well perfused tissues:
- first increase due to conc in well perfused tissue increasing from plasma
- drop in initial conc in well perfused tissues as the poorly perfused tissues are increasing in conc
Poorly perfused tissues:
-slow increase due to conc increasing in these tissues from plasma (distribution catching up in poorly perfused tissues)
=reach equilibrium: matching conc with plasma conc, well-perfused tissues and poorly perfused tissues
What model does rate of distribution and equilibration follow?
Multiple compartment model
How does drug protein binding affect distribution of a drug?
Only a free drug will be able to afford response at target receptor site and/or be eliminated
Why is drug-protein binding clinically important?
- high protein bound
- narrow theraputic index (toxic)
- low Vd
What could happend if a second drug was administered which binds to proteins more readily in comparison to the first drug?
Increased free first drug
- second drug dsiplaces first drug from binding proteins
- more free first drug to elicit a response
- could potentially cause harm (important in pregnancy, renal failure, hypoalbuminaemia)